• SPX
  • 5969.34
  • 0.35 %
  • 20.6299
  • DJI
  • 44296.51
  • 0.97 %
  • 426.1602
  • N225
  • 38283.85
  • 0.68 %
  • 257.6797
  • FTSE
  • 8262.08
  • 1.38 %
  • 112.8101
  • IXIC
  • 19003.65
  • 0.16 %
  • 31.2305
Monogram Orthopaedics, Inc. (MGRM) Stock Price, News & Analysis

Monogram Orthopaedics, Inc. (MGRM) Stock Price, News & Analysis

Currency in USD Disclaimer

$1.97

-$0.01

(-0.5%)

Day's range
$1.97
Day's range
$2.04
50-day range
$1.92
Day's range
$3.48
  • Country: US
  • ISIN: US6097861081
52 wk range
$1.53
Day's range
$4.9
  • CEO: Mr. Benjamin Sexson C.F.A.
  • Website: Visit Site


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 8.51
  • Piotroski Score 3.00
  • Grade N/A
  • Symbol (MGRM)
  • Company Monogram Orthopaedics, Inc.
  • Price $1.97
  • Changes Percentage (-0.5%)
  • Change -$0.01
  • Day Low $1.97
  • Day High $2.04
  • Year High $4.90

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was incorporated in 2016 and is headquartered in Austin, Texas.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 03/14/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Strong Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$0.42
  • Trailing P/E Ratio -5.36
  • Forward P/E Ratio -5.36
  • P/E Growth -5.36
  • Net Income $-13,745,217

Income Statement

Quarterly

Annual

Latest News of MGRM

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Monogram Orthopaedics, Inc. Frequently Asked Questions

  • What is the Monogram Orthopaedics, Inc. stock price today?

    Today's price of Monogram Orthopaedics, Inc. is $1.97 — it has decreased by -0.5% in the past 24 hours. Watch Monogram Orthopaedics, Inc. stock price performance more closely on the chart.

  • Does Monogram Orthopaedics, Inc. release reports?

    Yes, you can track Monogram Orthopaedics, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Monogram Orthopaedics, Inc. stock forecast?

    Watch the Monogram Orthopaedics, Inc. chart and read a more detailed Monogram Orthopaedics, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Monogram Orthopaedics, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Monogram Orthopaedics, Inc. stock ticker.

  • How to buy Monogram Orthopaedics, Inc. stocks?

    Like other stocks, MGRM shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Monogram Orthopaedics, Inc.'s EBITDA?

    Monogram Orthopaedics, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Monogram Orthopaedics, Inc.’s financial statements.

  • What is the Monogram Orthopaedics, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is -37.6582319404, which equates to approximately -3,765.82%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Monogram Orthopaedics, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Monogram Orthopaedics, Inc.'s financials relevant news, and technical analysis. Monogram Orthopaedics, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Monogram Orthopaedics, Inc. stock currently indicates a “sell” signal. For more insights, review Monogram Orthopaedics, Inc.’s technical analysis.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.